OmniAb, Inc.

Ab Initio Biotherapeutics Inc., Crystal Bioscience Inc., Icagen LLC, OmniAb Operations Inc., Taurus Biosciences LLC
Emeryville, California
Pharmaceuticals Biotechnology and Life Sciences

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Clear
Lower Risk

Summary:

OmniAb, Inc. is Lower Risk. The company does not yield to political activism in shaping corporate governance, preventing initiatives that potentially alienate consumers, divide employees, and harm shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. Overall, the company does not embrace corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach protects free exercise, free speech, and free enterprise.

View Full Corporate Bias Ratings Report
Criteria
Risk Level
Rationale
Corporate Weaponization
Criteria

Has canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.

Risk Level
Rationale

OmniAb, Inc. has not publicly canceled customers, suppliers, or vendors based on political views or religious beliefs (1).

Criteria

Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.

Risk Level
N/A
Rationale

OmniAb, Inc. does not publish charitable giving guidelines (1).

Criteria

Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.

Risk Level
Rationale

OmbiAb appears to prioritize diversity over merit in its recruitment, hiring, promotions, and mentorship program. From its 2023 Annual Report: “We prioritize diversity, equity, and inclusion in all aspects of our company, including hiring, promotion, and development practices” (1). The company has a history of divisive corporate policies and practices. However, in December 2024, the company removed DEI language and policies from its Annual Report. To date, the company has not publicly addressed this change, leaving shareholders without clarity regarding the company’s reasoning or future direction (2). OmniAb does not provide viewpoint protections for its employees (3).

Corporate Governance and Public Policy
Criteria

Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.

Risk Level
Rationale

OmniAb supports DEI within its buisness practices. From its 2023 Annual Report: “We prioritize diversity, equity, and inclusion in all aspects of our company… We believe our Company is stronger because of our employees’diverse experiences and backgrounds” (1). The company has a history of divisive corporate policies and practices and using its reputation to support divisive praactices. However, in December 2024, the company removed DEI from its Annual Report. To date, the company has not publicly addressed this change, leaving shareholders without clarity regarding the company’s reasoning or future direction (2).

Criteria

Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.

Risk Level
Rationale

OmniAb, Inc. has not used corporate funds to advance ideological causes, organizations, or policies (1).

Criteria

Uses corporate political actions and/or financial contributions for ideological, non-business purposes.

Risk Level
N/A
Rationale

OmniAb, Inc. does not operate a PAC or engage in lobbying at this time (1)(2)(3).

Board Bias

Expand Summary

1792 Exchange has not yet compiled data about the board of directors or political contributions of leadership for this company.

Generate Reports
Clear
Toast